UPDATE: ZyCoV-D, developed by an Ahmedabad-based leading pharmaceutical company Zydus Cadila, has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) on 20 August 2021. [1] With the announcement, ZyCoV-D became the world's first needle-free three-dose ...